Selective urethrectomy following cystoprostatectomy for bladder cancer

The Journal of Urology
D P HickeyW M Murphy

Abstract

The poor prognosis in patients who have symptomatic urethral carcinoma after cystoprostatectomy has prompted some investigators to recommend prophylactic urethrectomy. However, this approach subjects the majority of these patients (up to 90 per cent) to an operation for a disease that they might never have and precludes some innovative urinary diversion techniques. From June 1976 to July 1985 we performed 75 cystoprostatectomies for bladder cancer in men. Three patients underwent simultaneous urethrectomy because of tumor in the urethra. Of the remaining 72 patients who were followed by urethral wash cytology studies every 6 months 7 (10 per cent) had positive cytology studies during followup and underwent urethrectomy. Subsequent histological examination showed carcinoma in situ in all 7 specimens. To date 6 of the 7 patients are free of disease. One patient died 18 months after urethrectomy without evidence of transitional cell carcinoma. We have had no false positive urethral wash cytology studies and no patient has had local recurrence in the absence of a positive cytology study.

References

Sep 1, 1977·The American Journal of Surgical Pathology·W H WolinskaW F Whitmore
Jun 1, 1975·Cancer·M A BatataH Grabstald
Jan 11, 1976·The Journal of Urology·P F Schellhammer, W F Whitmore
Jan 11, 1976·The Journal of Urology·P F Schellhammer, W F Whitmore
Oct 1, 1985·British Journal of Urology·A G CouttsJ W Fowler
Aug 1, 1973·British Journal of Urology·C B Williams, J P Mitchell
Feb 1, 1974·The Journal of Urology·U K StamsR J Veenema
Feb 1, 1971·British Journal of Urology·D S Poole-Wilson, R J Barnard
Nov 1, 1984·The Journal of Urology·O M Lilien, M Camey
Feb 1, 1984·The Journal of Urology·J R BeahrsH Zincke
Feb 1, 1984·The Journal of Urology·A Zabbo, J E Montie
Mar 1, 1956·British Journal of Urology·A ASHWORTH
Dec 1, 1960·British Journal of Urology·N F GOWING
Mar 1, 1962·The Journal of Urology·J J CORDONNIER, H J SPJUT

❮ Previous
Next ❯

Citations

Feb 11, 2003·The Journal of Urology·Daniel W LinGuido Dalbagni
Aug 31, 2004·Japanese Journal of Clinical Oncology·Taiji TsukamotoNaoya Masumori
Jul 1, 1990·The Journal of Urology·A K LevinsonK I Wishnow
Nov 1, 1989·The Journal of Urology·F Schreiter, F Noll
Jan 1, 1990·Scandinavian Journal of Urology and Nephrology·W Månsson, S Colleen
Jan 1, 1996·World Journal of Urology·M ErckertG Bartsch
Jan 1, 1989·Scandinavian Journal of Urology and Nephrology·M NurmiT Ekfors
Feb 1, 1988·The Journal of Urology·D K HermansenM R Melamed
Dec 1, 1989·The Journal of Urology·H Van PoppelL Baert
Jun 21, 2002·European Urology·Arnulf StenzlHermann Rogatsch
Aug 6, 2003·Critical Reviews in Oncology/hematology·Hein Van Poppel, Tomas Sorgeloose
Aug 6, 2003·Critical Reviews in Oncology/hematology·Arnulf Stenzl, Lorenz Höltl
Dec 19, 2003·The Urologic Clinics of North America·Bernard H BochnerCheryl T Lee
May 3, 2005·The Urologic Clinics of North America·Peter E Clark, M Craig Hall
Jul 28, 2006·Annales D'urologie·H Van Poppel, D Thuer
Feb 7, 2007·Urology·UNKNOWN World Health Organization (WHO) Consensus Conference on Bladder CancerBjoern G Volkmer
Mar 23, 1999·The Urologic Clinics of North America·M C Benson, C A Olsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.